BIOMAT Database Logo BIOMAT Database Logo

Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial. 1989

J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Nephrology Department, Hospital 1. de Octubre, Facultad de Medicina, Madrid, Spain.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005260 Female Females

Related Publications

J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
February 1992, Transplantation proceedings,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?
January 1991, Nephron,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
"Cyclosporine-A nephrotoxicity in renal allograft recipients".
January 1985, Journal of nephrology nursing,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
January 2000, Journal of cardiovascular pharmacology,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
January 2007, Clinical transplantation,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial.
October 1987, Transplantation proceedings,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial.
May 1990, Transplantation,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.
August 2002, Transplantation proceedings,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation.
July 1991, Transplantation,
J M Morales, and A Andrés, and C Prieto, and B Ortuño, and J Estenoz, and C Dorado, and J Arenas, and L M Ruilope, and L Fernández-Cruz, and J L Rodicio
Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
August 1985, Transplantation proceedings,
Copied contents to your clipboard!